Diabetes and the risk of prostate cancer

Michał Kamil Wrzosek, Robert Jarema, Paweł Piątkiewicz
Clinical Diabetology 2012;1(4):152-158.

open access

Vol 1, No 4 (2012)
Review articles (submitted)
Published online: 2012-11-27


Diabetes mellitus (DM) is one of the fastest deadly
growing diseases around the world and prostate cancer (CaP) is one of the most common types of
cancer among men and it has the highest mortality
after lung cancer in the United States of America
(USA). It is interesting that epidemiologic evidence
suggests that the occurrence of DM is related to
a decreased CaP risk. The cause of this association
remains largely unknown. DM and CaP are influenced
by many factors, e.g.: environmental, hormonal,
immunological and genetic. The aim of this study
was to underline the role of certain factors that
may influence the inverse relationship between
prostate cancer and diabetes and to asses the
currently proposed hypotheses for understanding
the mecha-nism of this process.


cukrzyca typu 2; rak prostaty

About this article

Diabetes and the risk of prostate cancer


Clinical Diabetology


Vol 1, No 4 (2012)



Published online


Bibliographic record

Clinical Diabetology 2012;1(4):152-158.


cukrzyca typu 2
rak prostaty


Michał Kamil Wrzosek
Robert Jarema
Paweł Piątkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl